Table 2.
Measure | CBT (N=50) | Enhanced usual care (N=51) | p | ||
---|---|---|---|---|---|
|
|
||||
M | SD | M | SD | ||
SCL | |||||
Baseline | 1.83 | .12 | 1.75 | .11 | .596 |
6 weeks | 1.35 | .12 | 1.48 | .12 | .474 |
3 months | 1.00 | .13 | 1.21 | .13 | .259 |
6 months | .82 | .12 | 1.14 | .13 | .073 |
PHQ-9 | |||||
Baseline | 17.02 | .82 | 17.34 | .81 | .785 |
6 weeks | 10.71 | .91 | 12.15 | .90 | .262 |
3 months | 8.23 | .94 | 10.08 | .93 | .165 |
6 months | 5.81 | .88 | 9.64 | .95 | .003 |
Based on a repeated-measures linear mixed-effects model that controlled for presence of comorbid anxiety; possible SCL scores range from 0 to 4, and possible PHQ-9 scores range from 0 to 27, with higher scores indicating more severe depression.